Prevalence of Depression in Patients With Hypertension

Abstract Prevalence estimates of depression in hypertensive patients varied widely in existing studies. We conducted a systematic review and meta-analysis of observational studies to summarize the point prevalence of depressive symptoms in adults with hypertension. Comprehensive electronic searches of PubMed, Web of Knowledge, China National Knowledge Internet (CNKI), Wangfang, and Weipu databases were conducted to identify any study in each database published from initial state to November 31, 2014, reporting the prevalence of depression in hypertensive patients. Random-effects model was used to estimate the prevalence of depressive symptoms. We also limited the analyses to studies using clinical interview and prespecified criteria for diagnosis. All statistical calculations were made by using the Stata Version 12.0 (College Station, TX) and Statsdirect Version 2.7.9. We identified 41 studies with a total population of 30,796 in the present meta-analysis. The summarized prevalence of depression among hypertensive patients is 26.8% (95% confidence interval (CI): 21.7%–32.3%). Subgroup analysis shows the following results: for male 24.6%, 95% CI: 14.8%–35.9%, for female 24.4%, 95% CI: 14.6%–35.8%. For China: 28.5% (95% CI: 22.2%–35.3%); for other region (22.1%, 95% CI: 12.1%–34.1%); for community: 26.3% (95% CI: 17.7%–36.0%), for hospital: 27.2% (95% CI: 20.6%–34.5%). Estimated prevalence by interview was 21.3% (95% CI: 14.2%–30.0%); prevalence of depressive symptoms adjudicated by self-rating scales was 29.8% (95% CI: 23.3%–36.7%). The observed heterogeneity in depression prevalence of hypertension may be attributed to differences in method of evaluation. Self-report scales should be cautious of estimating the presence of depression. Thus, interview-defined depression affects approximately one third of hypertensive patients. Effective interventions for depression on patient-centered are needed.

[1]  K. Freedland,et al.  The prevalence of comorbid depression in adults with diabetes: a meta-analysis. , 2001, Diabetes care.

[2]  A. M. Pérez-García,et al.  Coping strategies, depressive symptoms and quality of life in hypertensive patients: Mediational and prospective relations , 2013, Psychology & health.

[3]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[4]  L. Aboussouan,et al.  Sleep Quality, Depression, and Quality of Life in Patients with Pulmonary Hypertension , 2011, Lung.

[5]  S. Danquah,et al.  Mental health in hypertension: assessing symptoms of anxiety, depression and stress on anti-hypertensive medication adherence , 2014, International Journal of Mental Health Systems.

[6]  S. Thompson,et al.  Quantifying heterogeneity in a meta‐analysis , 2002, Statistics in medicine.

[7]  G. Pucci,et al.  From hypertension to hypertrophy to heart failure: the role of cardiotrophin-1. , 2013, Journal of hypertension.

[8]  Ajay K. Singh,et al.  Hypertension in the developing world: challenges and opportunities. , 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[9]  M. Woodward,et al.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis , 2012, The Lancet.

[10]  W. Chaplin,et al.  Depression and clinical inertia in patients with uncontrolled hypertension. , 2014, JAMA internal medicine.

[11]  H. Bogner,et al.  Pilot trial of a licensed practical nurse intervention for hypertension and depression. , 2013, Family medicine.

[12]  C. Iadecola,et al.  Hypertension: A Harbinger of Stroke and Dementia , 2013, Hypertension.

[13]  Le-Xin Wang,et al.  Role of educational intervention in the management of comorbid depression and hypertension , 2003, Blood pressure.

[14]  Paul J Mills,et al.  Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. , 2006, Journal of the American College of Cardiology.

[15]  Julian M Somers,et al.  Prevalence and Incidence Studies of Mood Disorders: A Systematic Review of the Literature , 2004, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[16]  A. Stewart,et al.  The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. , 1989, JAMA.

[17]  M. Kendall,et al.  Kendall's advanced theory of statistics , 1995 .

[18]  E. Hummers-Pradier,et al.  Health and treatment priorities in patients with multimorbidity: Report on a workshop from the European General Practice Network meeting ‘Research on multimorbidity in general practice’ , 2010, The European journal of general practice.

[19]  C. Iadecola,et al.  A Harbinger of Stroke and Dementia , 2022 .

[20]  L. Bodanese,et al.  Association between Anxiety or Depressive Symptoms and Arterial Hypertension, and Their Impact on the Quality of Life , 2010, International journal of psychiatry in medicine.

[21]  David W. Johnson,et al.  Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. , 2013, Kidney international.

[22]  W. Caspary,et al.  Celiac disease , 2006, Orphanet journal of rare diseases.

[23]  E. Feskens,et al.  The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. , 2000, The New England journal of medicine.

[24]  E. Feskens,et al.  The Relation between Blood Pressure and Mortality Due to Coronary Heart Disease among Men in Different Parts of the World , 2000 .

[25]  P. Kimmel,et al.  The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. , 2006, Kidney international.

[26]  Lorena Hsu,et al.  Prevalence and Incidence Studies of Anxiety Disorders: A Systematic Review of the Literature , 2004, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[27]  J. Patel,et al.  Depression is linked to uncontrolled hypertension: a case–control study from Karachi, Pakistan , 2014, Journal of mental health.

[28]  J. McElnay,et al.  Exploring the impact of depressive symptoms and medication beliefs on medication adherence in hypertension--a primary care study. , 2008, Patient education and counseling.

[29]  M. Woodward,et al.  Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis , 2012, The Lancet.

[30]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[31]  A. Deev,et al.  [Depressive symptoms worsen cardiovascular prognosis and shorten length of life in patients with arterial hypertension and ischemic heart disease]. , 2011, Kardiologiia.

[32]  Mohammed T Ansari,et al.  Quality Assessment Forms , 2010 .

[33]  P. Coventry Multicondition collaborative care intervention for people with coronary heart disease and/or diabetes, depression and poor control of hypertension, blood sugar or hypercholesterolemia improves disability and quality of life compared with usual care , 2012, Evidence-Based Medicine.

[34]  N. Meader,et al.  Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. , 2011, The Lancet. Oncology.

[35]  B. Gaynes,et al.  Screening for Depression in Adult Patients in Primary Care Settings: A Systematic Evidence Review , 2009, Annals of Internal Medicine.

[36]  L. Ried,et al.  Validating a Self-report Measure of Global Subjective Well-being to Predict Adverse Clinical Outcomes , 2006, Quality of Life Research.